Table 1 Clinical data of the cohort
n | %* | |
|---|---|---|
Number of patients | 635 | |
Median age at time of VIT-initiation (years) (range) | 39 | (5–77) |
Male/female | 322/313 | |
Results of allergy testing | ||
Vespula (vulgaris/germanica) mono sensitization | 251 | 39.5 |
Honey bee (Apis mellifera) mono sensitization | 33 | 5.2 |
Double sensitization | 351 | 55.3 |
Severity of anaphylaxis to pre-VIT index field sting | ||
Large local reaction | 8 | 1.3 |
Grade I (mild) | 171 | 26.9 |
Grade II (moderate) | 321 | 50.6 |
Grade III (severe) | 135 | 21.3 |
Treatment course | ||
Mean duration of VIT (years) (range) | 3.9 | (3–13) |
Mean observation time after VIT (years) (range) | 7.0 | (0–17) |